Cancer is a leading cause of death worldwide. It is estimated that more than 50% of the people in the UK who are currently under the age of 65 will be diagnosed with cancer during their lifetime. While significant research has been carried out in therapeutic development, treatment of many different cancers still remains as an unmet clinical need. Thus, there is a necessity for new therapeutic approaches.